Frederick Beddingfield III's Net Worth
$8.96 Million
Who is Frederick Beddingfield III?
Frederick Beddingfield III has an estimated net worth of $8.96 Million. This is based on reported shares across multiple companies, which include KYTHERA BIOPHARMACEUTICALS INC, and Sienna Biopharmaceuticals, Inc..
SEC CIK
Frederick Beddingfield III's CIK is 0001573074
Past Insider Trading and Trends
2019 was Frederick Beddingfield III's most active year for acquiring shares with 11 total transactions. Frederick Beddingfield III's most active month to acquire stocks was the month of December. 2015 was Frederick Beddingfield III's most active year for disposing of shares, totalling 14 transactions. Frederick Beddingfield III's most active month to dispose stocks was the month of July. 2015 saw Frederick Beddingfield III paying a total of $2,784,566.01 for 206,735 shares, this is the most they've acquired in one year. In 2015 Frederick Beddingfield III cashed out on 365,225 shares for a total of $11,633,416.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KYTHERA BIOPHARMACEUTICALS INC No price found
Chief Medical OfficerFrederick Beddingfield III used to own units in Common Stock but no longer holds any shares there.acquired a total of 166,047 shares in KYTHERA BIOPHARMACEUTICALS INC at a cost of $2,784,566.01, Frederick also disposed a total of 166,622 shares of KYTHERA BIOPHARMACEUTICALS INC equalling to $11,827,501.34.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -575.00 |
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
$50.04 | -$5,502,994.66 |
0
|
Sep 24
| |||
Form 4
| -100.00% | -30.58K |
$75.66 | -$2,314,015.12 |
0
|
Jun 24 - Jun 25
| |||
Form 4
| -30.19% | -13.22K |
$53.79 | -$711,430.50 | 30.58K |
Jun 4
| |||
Form 4
| +8.33% | 3.37K |
$45.51 | -$92,885.91 | 43.81K |
Apr 29 - Apr 30
| |||
Form 4
| -10.59% | -4.79K |
$47.50 | -$227,524.04 | 40.44K |
Mar 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| -9.54% | -4.77K |
$40.69 | -$194,085.10 | 45.23K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sienna Biopharmaceuticals, Inc. No price found
President & CEOFrederick Beddingfield III owns 967,599 units of Common Stock. In the year 2017 Frederick Beddingfield III filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.35% | 150K |
—
|
—
| 967.6K |
Aug 6
| |||
Form 4
| -2.04% | -17.06K |
$0.76 | -$12,967.88 | 817.6K |
Jul 2
| |||
Form 4
| +5.05% | 40K |
$2.50 | $100,000.00 | 831.66K |
Feb 22
| |||
Form 4
| +31.03% | 187.5K |
—
|
—
| 791.66K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +8.60% | 47.59K |
—
|
—
| 601.25K |
May 17
| |||
Form 4
|
∞
| 140.77K |
—
|
—
| 140.77K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||